![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ![]() Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. | ![]() PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. | ![]() Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | ||
Founding Date | Founding Date 2002 | Founding Date 2016 | Founding Date 1981 | Founding Date 2002 | Founding Date 2000 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Oakland, US HQ | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Malvern, US HQ | Locations Aachen, DE HQ Mönchengladbach, DE Cambridge, GB |
Employees | Employees 58415% increase | Employees 109% decrease | Employees 9,9041% decrease | Employees 22 | Employees 3218% decrease |
Valuation ($) | Valuation ($) 3.1 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 32.7 m | Valuation ($) 60.2 m |
Twitter followers | Twitter followers 2 k | Twitter followers N/A | Twitter followers 59.6 k | Twitter followers 298 | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 4.4 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 4.5 | Average likes per tweet (last 30 days) 1.3 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 66.67% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 256484 | Alexa Website Rank N/A | Alexa Website Rank N/A | Alexa Website Rank 637541 | Alexa Website Rank 529818 |
Employee Rating | Employee Rating 2.9 | Employee Rating N/A | Employee Rating N/A | Employee Rating 5 | Employee Rating 3 |
Financial | |||||
Revenue (est.) | Revenue (est.) $260.9m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $320k (FY, 2020) | Revenue (est.) €7.1m (FY, 2021) |
Cost of goods | Cost of goods $31m (FY, 2020) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods (€1.5m) (FY, 2021) |
Gross profit | Gross profit $229.8m (FY, 2020) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit €5.6m (FY, 2021) |
Net income | Net income ($276.9m) (FY, 2020) | Net income N/A | Net income N/A | Net income ($98.6m) (FY, 2020) | Net income (€21.8m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 30m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 15.2m |
Modis Therapeutics develops treatments for rare genetic diseases.
View companySanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View companyPhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View companyPAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
View company